semaglutide and depression The risk of depression, anxiety, suicidal behavior in patients with obesity on glucagon like peptide-1 receptor agonist therapy The GLP-1 semaglutide (#Ozempic) failed

WARNINGS Keep out of the reach of young children

Respondents were included as having diabetes if they stated that they had ever been told by a doctor or other health professional that they had type 2 diabetes or did not know their specific type of diabetes (those with type 1 diabetes and other type of diabetes were excluded)

Worster AA, et al

The levels of the hormone measured as area under the curve (AUC) increased up to 55501090 g/L/240 min vs

Conclusion As GLP-1s have gained popularity, people have begun to stigmatize those who lose weight using GLP-1s

The FDA also recently approved an oral version of Wegovy, which was previously only offered as an injectable